Walgreens Boots Alliance, Inc. (NASDAQ:WBA) Shares Sold by Ceeto Capital Group LLC

Ceeto Capital Group LLC lessened its holdings in shares of Walgreens Boots Alliance, Inc. (NASDAQ:WBA) by 52.7% in the first quarter, according to its most recent filing with the SEC. The firm owned 15,700 shares of the pharmacy operator’s stock after selling 17,500 shares during the quarter. Ceeto Capital Group LLC’s holdings in Walgreens Boots Alliance were worth $341,000 as of its most recent SEC filing.

Several other institutional investors have also modified their holdings of WBA. Assenagon Asset Management S.A. lifted its holdings in shares of Walgreens Boots Alliance by 52.5% in the fourth quarter. Assenagon Asset Management S.A. now owns 278,357 shares of the pharmacy operator’s stock valued at $7,268,000 after buying an additional 95,828 shares during the period. Planned Solutions Inc. acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at $34,000. Blue Trust Inc. lifted its holdings in shares of Walgreens Boots Alliance by 115.7% in the fourth quarter. Blue Trust Inc. now owns 1,775 shares of the pharmacy operator’s stock valued at $46,000 after buying an additional 952 shares during the period. Caprock Group LLC acquired a new stake in shares of Walgreens Boots Alliance in the fourth quarter valued at $273,000. Finally, Hennessy Advisors Inc. raised its position in shares of Walgreens Boots Alliance by 30.8% during the fourth quarter. Hennessy Advisors Inc. now owns 162,500 shares of the pharmacy operator’s stock worth $4,243,000 after purchasing an additional 38,250 shares during the period. Institutional investors and hedge funds own 58.59% of the company’s stock.

Analysts Set New Price Targets

A number of brokerages have recently issued reports on WBA. Bank of America reaffirmed an “underperform” rating and set a $11.00 target price (down from $22.00) on shares of Walgreens Boots Alliance in a research report on Friday, June 28th. JPMorgan Chase & Co. cut their target price on Walgreens Boots Alliance from $30.00 to $20.00 and set an “overweight” rating on the stock in a research report on Monday, July 1st. UBS Group cut their target price on Walgreens Boots Alliance from $17.00 to $12.00 and set a “neutral” rating on the stock in a research report on Wednesday, July 3rd. Barclays cut their target price on Walgreens Boots Alliance from $11.00 to $7.00 and set an “underweight” rating on the stock in a research report on Tuesday, July 23rd. Finally, Truist Financial dropped their price target on Walgreens Boots Alliance from $20.00 to $13.00 and set a “hold” rating on the stock in a research report on Friday, June 28th. Four equities research analysts have rated the stock with a sell rating, eleven have issued a hold rating and two have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Hold” and an average target price of $16.86.

Walgreens Boots Alliance Stock Up 2.7 %

NASDAQ WBA traded up $0.31 on Friday, reaching $11.82. The stock had a trading volume of 14,503,093 shares, compared to its average volume of 25,245,074. The company has a market capitalization of $10.20 billion, a price-to-earnings ratio of -1.75, a P/E/G ratio of 0.83 and a beta of 0.72. The business has a 50 day moving average price of $13.94 and a 200 day moving average price of $18.12. Walgreens Boots Alliance, Inc. has a 1 year low of $10.69 and a 1 year high of $31.32. The company has a current ratio of 0.65, a quick ratio of 0.31 and a debt-to-equity ratio of 0.49.

Walgreens Boots Alliance (NASDAQ:WBA) last released its quarterly earnings results on Thursday, June 27th. The pharmacy operator reported $0.63 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.68 by ($0.05). The company had revenue of $36.40 billion for the quarter, compared to the consensus estimate of $35.94 billion. Walgreens Boots Alliance had a positive return on equity of 12.63% and a negative net margin of 3.99%. The business’s revenue was up 2.8% compared to the same quarter last year. During the same quarter last year, the company posted $1.00 EPS. On average, analysts forecast that Walgreens Boots Alliance, Inc. will post 2.87 EPS for the current fiscal year.

Walgreens Boots Alliance Announces Dividend

The business also recently declared a quarterly dividend, which will be paid on Thursday, September 12th. Stockholders of record on Wednesday, August 21st will be paid a dividend of $0.25 per share. The ex-dividend date of this dividend is Wednesday, August 21st. This represents a $1.00 annualized dividend and a dividend yield of 8.46%. Walgreens Boots Alliance’s dividend payout ratio (DPR) is presently -14.84%.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc operates as a healthcare, pharmacy, and retail company in the United States, the United Kingdom, Germany, and internationally. It operates through three segments: U.S. Retail Pharmacy, International, and U.S. Healthcare. The U.S. Retail Pharmacy segment engages in operation of the retail drugstores, health and wellness services, specialty, and home delivery pharmacy services, which offers health and wellness, beauty, personal care and consumables, and general merchandise.